FindMyKOL

Evan Stein, MD

Enriched profile

Cardiovascular Disease

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Chicago, IL · Midwest · United StatesSpecialtyCardiovascular DiseaseFocusDyslipidemia / Lipid Disorders+3
Last active 2021FindMyKOL type: NationalLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2021NIH fundingNone on fileWhy? →

Evan Stein is a Dyslipidemia / Lipid Disorders physician. ClinicalTrials.gov lists 10 registered studies with this person as an investigator.

Data verified 13 Nov 2026

Overview

Updated 14 Nov 2026

Evan Stein, MD, is profiled from the public federal record. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 1 companies.

  • Top research focus: Dyslipidemia / Lipid Disorders
  • 10 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 14 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Dyslipidemia / Lipid Disorders7 trialsCardiovascular Diseases3 trialsVascular Diseases3 trialsHomozygous Familial Hypercholesterolemia1 trialHypertriglyceridemia1 trialMyocardial Infarction1 trialStroke1 trial

Research focus

OpenAlex concept fingerprint
Dyslipidemia / Lipid DisordersCardiovascular DiseasesVascular DiseasesMyocardial Infarction

Works with

trial sponsors and companies reporting payments
LIB Therapeutics LLCClinical trials7Industry payments—Alkermes, Inc.Clinical trials—Industry payments4AstraZenecaClinical trials2Industry payments—Essentialis, Inc.Clinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2021–2021

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Nov 2026

Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Nov 2026

1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2020)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    PCSK9 Inhibitor46.3%
    Repatha Sureclick100%
    Part D<11 patients
    Cholesterol absorption inhibitor29.6%
    Ezetimibe100%
    Part D<11 patients

    + 1 more class in this area

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 13 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    cardiometabolichealth.org/faculty/evan-stein

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
  • Other

    hcplive.com/view/lerodalcibep-efficaciously-reduces-ldl-c-lastingly-and-long-term-with-evan-stein-md-phd

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.